Skip to main content
SpringerLink
Log in

Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results

  • Scientific Article
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

Background

Preoperative diffusion-weighted MRI (DW-MRI) has been described as an efficient method to differentiate good and poor responders to chemotherapy in osteosarcoma patients. A DW-MRI performed earlier during treatment could be helpful in monitoring chemotherapy.

Objective

To assess the accuracy of DW-MRI in evaluating response to chemotherapy in the treatment of osteosarcoma, more specifically at mid-course of treatment.

Materials and methods

This study was carried out on a prospective series of adolescents treated for long-bone osteosarcoma. MR examinations were performed at diagnosis (MRI-1), at mid-course of chemotherapy (MRI-2), and immediately before surgery (MRI-3). A DW sequence was performed using diffusion gradients of b0 and b900. The apparent diffusion coefficients (ADC1, ADC2, ADC3, respectively), their differentials (ADC2 − ADC1 and ADC3 − ADC1), and their variation (ADC2 − ADC1/ADC1 and ADC3 − ADC1/ADC1) were calculated for each of these three time points.

Results

Fifteen patients were included. Patients with no increase in ADC showed a poor response to chemotherapy on their histology results. At mid-course, the three calculated values were significantly different between good and poor responders. ADC2 − ADC1 enabled us to detect, with 100% specificity, four out of seven of the poor responders. There was no significant difference in the values at MRI-3 between the two groups.

Conclusion

DW-MRI performed both at baseline and mid-course of neoadjuvant chemotherapy is an efficient method to predict further histological response of osteosarcoma. This method could be used as an early prognostic factor to monitor preoperative chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bacci G, Longhi A, Versari M, et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvantchemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006;106(5):1154–6

    Google Scholar 

  2. Le Deley MC, Guinebretière JM, Gentet JC, Société Française d’Oncologie Pédiatrique (SFOP), et al. SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients. Eur J Cancer. 2007;43(4):752–61.

    Article  PubMed  Google Scholar 

  3. Kim MS, Lee SY, Cho WH, et al. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients. J Surg Oncol. 2008;97(5):456-61

    Google Scholar 

  4. Bajpai J, Gamnagatti S, Kumar R, et al. Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis. Pediatr Radiol. 2010;41(4):441–50.

    Article  PubMed  Google Scholar 

  5. Bramer JA, van Linge JH, Grimer RJ, et al. Prognostic factors in localized extremity osteosarcoma: a systematic review. Eur J Surg Oncol. 2009;35(10):1030–6.

    Article  PubMed  CAS  Google Scholar 

  6. Brisse H, Ollivier L, Edeline V, et al. Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment. Pediatr Radiol. 2004;34:595–605.

    Article  PubMed  Google Scholar 

  7. Pan G, Raymond AK, Carrasco CH, Wallace S, et al. Osteosarcoma: MR imaging after preoperative chemotherapy. Radiology. 1990;174:517–26.

    PubMed  CAS  Google Scholar 

  8. Holscher HC, Bloem JL, Vanel D, et al. Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology. 1992;182:839–44.

    PubMed  CAS  Google Scholar 

  9. Van der Woude HJ, Bloem JL, Verstraete KL, et al. Osteosarcoma and Ewing’s sarcoma after neoadjuvent chemotherapy: value of dynamic MR Imaging in detecting viable tumor before surgery. AJR Am J Roentgenol. 1995;165:593–8.

    PubMed  Google Scholar 

  10. Verstraete KL, Van der Woude HJ, et al. Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging. 1996;6:311–21.

    Article  PubMed  CAS  Google Scholar 

  11. Reddick WE, Wang S, Xiong X, et al. Dynamic magnetic resonance Imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer. 2001;91(12):2230–7.

    Article  PubMed  CAS  Google Scholar 

  12. Dyke JP, Panicek DM, Healey JH, et al. Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast- enhanced MR Imaging. Radiology. 2003;228:271–8.

    Article  PubMed  Google Scholar 

  13. Uhl M, Saueressig U, van Buiren M, Kontny U, et al. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Invest Radiol. 2006;41(8):618–23.

    Article  PubMed  CAS  Google Scholar 

  14. Ongolo-Zogo P, Thiesse P, Sau J, Desuvinges C, et al. Assessment of osteosarcoma response to neoadjuvent chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99 m skeletal angioscintigraphy. Eur Radiol. 1999;9:907–14.

    Article  PubMed  CAS  Google Scholar 

  15. Van Rijswijk CSP, Kunz P, Hogendoorn PCW, et al. Diffusion-weighted MRI in the characterization of soft-tissue tumors. J Magn Reson Imaging. 2002;15:302–7.

    Article  PubMed  Google Scholar 

  16. Baur A, Huber A, Arbogast S, et al. Diffusion-weighted imaging of tumor recurrencies and posttherapeutical soft-tissue changes in humans. Eur Radiol. 2001;11:828–33.

    Article  PubMed  CAS  Google Scholar 

  17. Baur A, Reiser MF. Diffusion-weighted imaging of the musculoskeletal system in humans. Skeletal Radiol. 2000;29:555–62.

    Article  PubMed  CAS  Google Scholar 

  18. Herneth AM, Friedrich K, Weidekamm C, Schibany N, et al. Diffusion weighted imaging of bone marrow pathologies. Eur J Radiol. 2005;55:74–83.

    Article  PubMed  Google Scholar 

  19. MacKenzie JD, Gonzalez L, Hernandez A. Diffusion-weighted and diffusion tensor imaging for pediatric musculoskeletal disorders. Pediatr Radiol. 2007;37:781–8.

    Article  PubMed  Google Scholar 

  20. Nonomura Y, Yasumoto M, Yoshimura R, Haraguchi K, et al. Relationship between bone marrow cellularity and apparent diffusion coefficient. J Magn Reson Imaging. 2001;13:757–60.

    Article  PubMed  CAS  Google Scholar 

  21. Humphries PD, Sebire NJ, Siegel MJ, et al. Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology. 2007;245(3):848–54.

    Article  PubMed  Google Scholar 

  22. Lang P, Wendland MF, Saeed M, Gindele A, Rosenau W. Osteogenic osteosarcoma: non-invasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging. Radiology. 1998;206:227–35.

    PubMed  CAS  Google Scholar 

  23. Thoeny HC, De Keyser F, Chen F. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology. 2005;234:756–64.

    Article  PubMed  Google Scholar 

  24. Uhl M, Saueressig U, Koehler G. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas. Pediatr Radiol. 2006;36:1306–11.

    Article  PubMed  Google Scholar 

  25. Hayashida Y, Yakushiji T, Awai K. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted images: initial results. Eur Radiol. 2006;16:2637–43.

    Article  PubMed  Google Scholar 

  26. Oka K, Yakushiji T, Sato H. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol. 2010;39(2):141–6.

    Article  PubMed  Google Scholar 

  27. Denecke T, Hundsdörfer P, Misch D, et al. Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters. Eur J Nucl Med Mol Imaging. 2010;37(10):1842–53.

    Article  PubMed  Google Scholar 

  28. Costelloe CM, Raymond AK, Fitzgerald NE, et al. Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis. Skeletal Radiol. 2010;39(2):131–40.

    Article  PubMed  Google Scholar 

  29. Cheon GJ, Kim MS, Lee JA, et al. Prediction model of chemotherapy response in osteosarcoma by 18 F-FDG PET and MRI. J Nucl Med. 2009;50(9):1435–40.

    Article  PubMed  CAS  Google Scholar 

  30. Hawkins DS, Conrad EU 3rd, Butrynski JE. [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer. 2009;115(15):3519-25.

    Google Scholar 

  31. Costelloe CM, Macapinlac HA, Madewell JE, et al. 18 F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med. 2009;50(3):340–7.

    Article  PubMed  Google Scholar 

  32. Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med. 1977;101(1):14–8.

    PubMed  CAS  Google Scholar 

  33. Parker GJ. Analysis of MR diffusion weighted images. Br J Radiol. 2004;77:S176–85.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Service d’imagerie pédiatrique et prénatale, Hôpital Timone Enfants, 264 Rue Sainte Pierre, 13385, Marseille Cedex 05, France

    C. Baunin, G. Schmidt, A. Aschero, A. Ruocco, B. Bourlière, G. Gorincour, C. Desvignes, N. Colavolpe & P. Petit

  2. Service de santé publique, Faculté de médecine de Marseille, 27 Bd Jean Moulin, 1385, Marseille Cedex 05, France

    K. Baumstarck & P. Auqier

  3. Service d’anatomopathologie, Hôpital Timone, 264 Rue Sainte Pierre, 13385, Marseille Cedex 05, France

    C. Bouvier

  4. Service d’oncologie pédiatrique, Hôpital Timone Enfants, 264 Rue Sainte Pierre, 13385, Marseille Cedex 05, France

    J. C. Gentet

  5. Service d’orthopédie pédiatrique, Hôpital Timone Enfants, 264 Rue Sainte Pierre, 13385, Marseille Cedex 05, France

    G. Bollini

Authors
  1. C. Baunin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Baumstarck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Bouvier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. C. Gentet
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Aschero
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Ruocco
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B. Bourlière
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Gorincour
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C. Desvignes
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. N. Colavolpe
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. G. Bollini
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. P. Auqier
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. P. Petit
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Petit.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baunin, C., Schmidt, G., Baumstarck, K. et al. Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results. Skeletal Radiol 41, 1141–1149 (2012). https://doi.org/10.1007/s00256-012-1360-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-012-1360-2

Keywords

Search

Navigation